[go: up one dir, main page]

AU2001282078A1 - Method for reducing specific immune reactions - Google Patents

Method for reducing specific immune reactions

Info

Publication number
AU2001282078A1
AU2001282078A1 AU2001282078A AU8207801A AU2001282078A1 AU 2001282078 A1 AU2001282078 A1 AU 2001282078A1 AU 2001282078 A AU2001282078 A AU 2001282078A AU 8207801 A AU8207801 A AU 8207801A AU 2001282078 A1 AU2001282078 A1 AU 2001282078A1
Authority
AU
Australia
Prior art keywords
specific immune
immune reactions
reducing specific
reducing
reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282078A
Inventor
Ahmed Sheriff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENETHOR GmbH
Original Assignee
GENETHOR GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENETHOR GmbH filed Critical GENETHOR GmbH
Publication of AU2001282078A1 publication Critical patent/AU2001282078A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001282078A 2000-08-09 2001-08-08 Method for reducing specific immune reactions Abandoned AU2001282078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10038722 2000-08-09
DE10038722A DE10038722C2 (en) 2000-08-09 2000-08-09 Procedure for the reduction of specific immune reactions
PCT/EP2001/009161 WO2002012453A1 (en) 2000-08-09 2001-08-08 Method for reducing specific immune reactions

Publications (1)

Publication Number Publication Date
AU2001282078A1 true AU2001282078A1 (en) 2002-02-18

Family

ID=7651752

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282078A Abandoned AU2001282078A1 (en) 2000-08-09 2001-08-08 Method for reducing specific immune reactions

Country Status (3)

Country Link
AU (1) AU2001282078A1 (en)
DE (1) DE10038722C2 (en)
WO (1) WO2002012453A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092795A2 (en) * 2001-05-16 2002-11-21 Genethor Gmbh Intracellular bonding of costimulatory molecules
DE10232697A1 (en) * 2002-07-15 2004-02-05 Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin Use of CD152 for the treatment of autoimmune diseases and inflammation
JP2014503185A (en) 2010-10-20 2014-02-13 ダニスコ・ユーエス・インク Thermostable TRICHODERMA cellulase
CN109620952A (en) * 2019-01-04 2019-04-16 北京中台恒基生物技术有限公司 A kind of tumor vaccine and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719972B1 (en) * 1994-06-03 2004-04-13 Repligen Corporation Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
EP1173550B1 (en) * 1999-05-04 2006-07-26 Genethor GmbH Method for diminishing specific immune reactions

Also Published As

Publication number Publication date
DE10038722A1 (en) 2002-03-07
DE10038722C2 (en) 2002-07-25
WO2002012453A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU7935300A (en) Dna isolation method
AU2651701A (en) Method for introducing additives
AU2002346628A1 (en) Method for improving dispatch response time
AU1854901A (en) Novel method
AU2111501A (en) Method for zeolite platinization
AU2001233699A1 (en) Method for selecting products
AU2406001A (en) Method for preparing glass-ceramic
AU2825400A (en) Two-dimensional separating method
AU2002214487A1 (en) Method for inducing apoptiosis
AU5650401A (en) Method for enhancing cognitive function
AU2001237530A1 (en) Method
AU2001282078A1 (en) Method for reducing specific immune reactions
AU2001291760A1 (en) Method and system for case conversion
AU3656900A (en) Granulation method
AU2001245513A1 (en) Method for immune switching
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001238996A1 (en) Method for individualising objects
AU1141501A (en) Method for producing hydroxymethylpyridines
AU1283001A (en) Method for producing alkylhalogenosilanes
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU5552200A (en) Method
AU4585100A (en) Method
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol
AU2001282931A1 (en) Method for induced lactation
AUPQ856700A0 (en) Method for creating geometric figures